Drug Type Small molecule drug |
Synonyms NOVO 118, NOVO118 |
Target |
Action modulators |
Mechanism LRP1 modulators(LDL receptor related protein 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| acute spinal cord injury | Clinical | United States | 20 Jul 2020 | |
| Multiple Sclerosis | Discovery | United States | 20 Jul 2020 | |
| Alzheimer Disease | Discovery | United States | - | |
| Brain Injuries, Traumatic | Discovery | United States | - | |
| Glaucoma | Discovery | United States | - |





